| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.00097 | 1 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.00091 | 1 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.0043 | 1 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.00099 | 1 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.00052 | 1 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.00044 | 1 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.00037 | 1 |